Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancer.

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Evaluation of survival data and two new rank order statistics arising in its consideration.

1966 • 7,595 citations

Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous Infusion

1982 • 768 citations

Terfenadine-Ketoconazole Interaction

1993 • 654 citations

Prognostic Factors for Survival in Patients With Inoperable Lung Cancer<xref ref-type="fn" rid="FN2">2</xref>

1980 • 569 citations

Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer.

1993 • 400 citations

A reevaluation of nonhormonal cytotoxic chemotherapy in the treatment of prostatic carcinoma.

1985 • 267 citations

Phase II study of estramustine and vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer.

1992 • 256 citations

Suramin: a novel growth factor antagonist with activity in hormone-refractory metastatic prostate cancer.

1992 • 237 citations

Estramustine and Vinblastine: Use of Prostate Specific Antigen as a Clinical Trial End Point for Hormone Refractory Prostatic Cancer

1992 • 206 citations

Chemotherapy for Small Cell Carcinoma of Prostatic Origin

1992 • 159 citations

An Acquired Chemotactic Defect in Neutrophils from Patients Receiving Interleukin-2 Immunotherapy

1990 • 149 citations

Ketoconazole: A Novel and Rapid Treatment for Advanced Prostatic Cancer

1983 • 133 citations

Non-hormone chemotherapy for prostate cancer: principles of treatment and application to the testing of new drugs.

1988 • 111 citations

Cyclic chemotherapy with cyclophosphamide, doxorubicin, and cisplatin plus vinblastine and bleomycin in advanced germinal tumors. Results with 100 patients

1986 • 103 citations

Sudden death during doxorubicin administration

1979 • 99 citations

High-dose ketoconazole in advanced hormone-refractory prostate cancer: endocrinologic and clinical effects.

1989 • 83 citations

Ketoconazole: A Possible Direct Cytotoxic Effect on Prostate Carcinoma Cells

1989 • 61 citations

Dermatologic toxicity of chemotherapy.

1992 • 56 citations

Ketoconazole therapy for hormonally refractive metastatic prostate cancer

1988 • 46 citations

Prostate Specific Antigen for Assessing Response to Ketoconazole and Prednisone in Patients with Hormone Refractory Metastatic Prostate Cancer

1990 • 35 citations

High Dose Ketoconazole for the Treatment of Hormone Refractory Metastatic Prostate Carcinoma: 16 Cases and Review of the Literature

1989 • 30 citations

Synergistic effect of ketoconazole and antineoplastic agents on hormone-independent prostatic cancer cells.

1989 • 12 citations

Etretinate increases carcinoembryonic antigen in palmar scrapings

1992 • 5 citations